Your Health, We Care
Release date: 2024-07-10 14:28:36 Recommended: 195
Ivosidenib (Tibsovo) is a potent oral IDH1 inhibitor primarily used to treat newly diagnosed adult patients aged ≥ 75 years or unable to use intensified induction chemotherapy due to comorbidities. Adult patients with recurrent or refractory AML. Used for adult patients with locally advanced or metastatic cholangiocarcinoma who have previously received treatment and carry IDH1 mutations detected by FDA approved testing methods. (This indication has not yet been approved in the Chinese market)
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：475Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：474Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：535Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：413Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：612Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：400Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：569Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：481Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：261Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：266Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：276Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：256Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：302Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：261Release date: 2025-12-01
